Tomomi Kimura

发表

East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians

Tomomi Kimura, Tomomi Kimura, 2012, Chinese journal of cancer.

Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety

Robert T. Chen, Kenneth K C Man, N. Pratt, 2021, Pharmacoepidemiology and drug safety.

[The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales].

Takuya Nishimura, Tomomi Kimura, Masaki Yoshida, 2020, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Changes in compliance with Japanese antiemetic guideline for chemotherapy-induced nausea and vomiting: a nationwide survey using a distributed research network

Norihiro Kobayashi, Tomomi Kimura, M. Kimura, 2014, Supportive Care in Cancer.

The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US

R. Aparasu, Tomomi Kimura, David R. Walker, 2021, PharmacoEconomics - Open.

Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population

Tomomi Kimura, David R. Walker, G. Lozano-Ortega, 2022, Neurourology and urodynamics.

Persistence and adherence to overactive bladder medications in Japan: A large nationwide real‐world analysis

Tomomi Kimura, S. Uno, D. Kato, 2017, International journal of urology : official journal of the Japanese Urological Association.

Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.

Tomomi Kimura, T. Sugitani, S. Stanhope, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review

T. Riley, Tomomi Kimura, 2018, Infectious Diseases and Therapy.

Anticholinergic burden in the Japanese elderly population: Use of antimuscarinic medications for overactive bladder patients

Takuya Nishimura, Tomomi Kimura, Masaki Yoshida, 2018, International journal of urology : official journal of the Japanese Urological Association.

Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder

R. Aparasu, Tomomi Kimura, David R. Walker, 2021, Drugs & Aging.

Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan

Kazuhito Shiosakai, Tomomi Kimura, Shinji Takahashi, 2012, Pharmaceutics.

Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.

Tomomi Kimura, T. Sugitani, R. Snijder, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis

Kenneth K C Man, E. Roughead, N. Pratt, 2016, Expert opinion on drug safety.

Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries

Michio Kimura, Nicole L. Pratt, Kiyoshi Kubota, 2015, Drug Safety.

Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries

Yea-Huei Kao Yang, Nicole Pratt, Michio Kimura, 2015, Pharmacoepidemiology and drug safety.

Multi‐country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study

E. Roughead, N. Pratt, U. Bergman, 2013, Pharmacoepidemiology and drug safety.

The Asian Pharmacoepidemiology Network (AsPEN): promoting multi‐national collaboration for pharmacoepidemiologic research in Asia

N. Pratt, U. Bergman, M. Kimura, 2013, Pharmacoepidemiology and drug safety.

Predicting recurrence and metastasis of Dukes' A primary colorectal cancer with or without proper muscle invasion.

N. Komatsu, H. Makuuchi, Tomomi Kimura, 2004, Oncology reports.

Drug Utilization Patterns in Patients with Diabetes Initiating Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Japan: A Multi-Database Study (2014–2017)

Takuya Nishimura, Tomomi Kimura, Yuichiro Ito, 2019, Diabetes Therapy.

Characteristics of Patients with Diabetes Initiating Sodium Glucose Co-transporter-2 Inhibitors (SGLT2i): Real-World Results from Three Administrative Databases in Japan

Takuya Nishimura, Tomomi Kimura, Yuichiro Ito, 2019, Diabetes Therapy.

Estimating the causal effect of transient anemia status on renal and cardiovascular outcomes in community-dwelling patients in Japan at the beginning of impaired renal function using marginal structural modeling

T. Akizawa, Tomomi Kimura, Yuichiro Ito, 2021, Clinical and Experimental Nephrology.

Passive surveillance of rotavirus gastroenteritis-associated hospitalization using nationwide administrative databases in Japan.

N. Okabe, Tomomi Kimura, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

CLINICAL AND ECONOMIC OUTCOMES OF PHARMACOLOGICAL STRESS TESTS IN PATIENTS WITH A HISTORY OF COVID-19

K. Davies, H. Skali, Tomomi Kimura, 2022, Journal of the American College of Cardiology.

Cost, resource utilization, and treatment-taking behaviors among patients with OAB initiating combination mirabegron and antimuscarinic therapy in the US

S. Kraus, Tomomi Kimura, David R. Walker, 2022, Continence Reports.

Validation and Recalibration of Charlson and Elixhauser Comorbidity Indices Based on Data From a Japanese Insurance Claims Database

Takuya Nishimura, Tomomi Kimura, Masanori Ito, 2019, Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku.

Validation and Recalibration of Charlson and Elixhauser Comorbidity Indices to Predict In-hospital Mortality in Hospitalized Patients in a Japanese Hospital-Based Administrative Database

Takuya Nishimura, Tomomi Kimura, Masanori Ito, 2020, Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku.

Diagnosis Patterns of CKD and Anemia in the Japanese Population

Tomomi Kimura, K. Nozaki, R. Snijder, 2020, Kidney international reports.

4. Large, Automated Administrative and Clinical Databases Available for Pharmacoepidemiology Studies in Japan

Daisuke Koide, Takao Orii, Tomomi Kimura, 2013 .

Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.

Tomomi Kimura, Masanori Ito, S. Onozawa, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

D*D:Analytical Clinical Information Retrieval System based on Hospital Information System-Overview and Use Examples-

Tomomi Kimura, J. Kawakami, K. Hori, 2010 .

Multi‐country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study

E. Roughead, N. Pratt, U. Bergman, 2013, Pharmacoepidemiology and Drug Safety.

Pharmacovigilance systems and databases in Korea, Japan, and Taiwan

Byung-Joo Park, Nam-Kyong Choi, Tomomi Kimura, 2011, Pharmacoepidemiology and drug safety.

Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis

Kenneth K C Man, E. Roughead, N. Pratt, 2016, Expert opinion on drug safety.